Improving donor heart preservation

European Journal of Cardio-thoracic Surgery

Volumn 41, Issue 4, 2012, Pages

  Weisel, Richard D ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Ageing; Cardiac transplantation; Cardioplegia; Myocardial preservation

Indexed keywords

PRESERVATION SOLUTION; CARDIOPLEGIC AGENT;

GRAFT PRESERVATION; HEART MUSCLE ISCHEMIA; HEART PRESERVATION; HEART VENTRICLE FUNCTION; HUMAN; ISCHEMIC PRECONDITIONING; NOTE; ORGAN DONOR; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURGEON; SURGICAL MORTALITY; CHEMICALLY INDUCED DISORDER; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; MALE; METHODOLOGY; ORGAN PRESERVATION;

CARDIOPLEGIC SOLUTIONS; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MALE; ORGAN PRESERVATION;

EID: 84862312042     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezs058     Document Type: Note

References (10)

1. Cannata A, Botta L, Colombo T, Russo CF, Taglieri C, Bruschi G et al. Does the cardioplegic solution have an effect on early outcomes following heart transplantation? Eur J Cardiothorac Surg (this issue).
2. Fedak P, Rao V, Verma S, Ramzy D, Tumiati L, Miriuka S et al. Combined endothelial and myocardial protection by endothelin antagonism enhances transplant allograft preservation. J Thorac Cardiovasc Surg 2005;129:407-15.
3. Bruschi G, Colombo T, Oliva F, Morici N, Botta L, Cannata A et al. Orthotopic heart transplantation with donors greater than or equal to 60 years of age: a single-center experience. Eur J Cardiothorac Surg 2011;40:e55-61.
4. McCully JD, Toyoda Y, Wakiyama H, Rousou AJ, Parker RA, Levitsky S. Age- and gender-related differences in ischemia/reperfusion injury and cardioprotection: effects of diazoxide. Ann Thorac Surg 2006;82:117-23.
5. Zhuo Y, Li S-H, Chen M-S, Wu J, Kinkaid HYM, Fazel S et al. Aging impairs the angiogenic response to ischemic injury and the activity of implanted cells: combined consequences for cell therapy in older recipients. J Thorac Cardiovasc Surg 2010;139:1286-94.
6. Lee S, Huang C-S, Kawamura T, Shigemura N, Biliar TR, Nakao A et al. Histidine-tryptophan-ketoglutarate or celsior: which is more suitable for cold preservation for cardiac grafts from old donors. Ann Thorac Surg 2011;91:755-63.
7. Kevelaitis E, Oubénaissa A, Mouas C, Peynet J, Menasché P. Ischemic preconditioning with opening of mitochondrial adenosine triphosphatesensitive potassium channels or Na+/H+ exchange inhibition: which is the best protective strategy for heart transplants? J Thorac Cardiovasc Surg 2001;121:155-62.
8. Rao V, Feindel CM, Cohen G, Borger MA, Ross HJ, Weisel RD Effects of metabolic stimulation on cardiac allograft recovery. Ann Thorac Surg 2001;71:219-25.
9. Rao V, Feindel CM, Weisel RD, Boylen P, Cohen G. Donor blood perfusion improves myocardial recovery following cardiac transplantation. J Heart Lung Transplant 1997;16:667-73.
10. Collins MJ, Moainie SL, Griffith BP, Poston RS. Preserving and evaluating hearts with ex vivo machine perfusion: an avenue to improve early graft performance and expand the donor pool. Eur J Cardiothorac Surg 2008; 34:318-25.